222 related articles for article (PubMed ID: 31962001)
1. Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre-invasive phenomena that is prognostic in invasion.
Shaker H; Bundred NJ; Landberg G; Pritchard SA; Albadry H; Nicholson SL; Harries LJ; Heah JYE; Castle J; Kirwan CC
Cancer Med; 2020 Mar; 9(5):1768-1778. PubMed ID: 31962001
[TBL] [Abstract][Full Text] [Related]
2. PO-21 - Stromal fibroblasts in preinvasive breast cancer (ductal carcinoma in situ, DCIS) demonstrate a cancer-like procoagulant phenotypic switch that may facilitate invasion.
Shaker H; Bundred NJ; Albadry H; Nicholson S; Castle J; Lumsden LJ; Pritchard S; Landberg G; Kirwan CC
Thromb Res; 2016 Apr; 140 Suppl 1():S184. PubMed ID: 27161710
[TBL] [Abstract][Full Text] [Related]
3. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
5. CD133 expressionand clinicopathologic significance in benign and malignant breast lesions.
Liu TT; Li XF; Wang L; Yang JL
Cancer Biomark; 2020; 28(3):293-299. PubMed ID: 32390595
[TBL] [Abstract][Full Text] [Related]
6. Overall survival is improved when DCIS accompanies invasive breast cancer.
Kole AJ; Park HS; Johnson SB; Kelly JR; Moran MS; Patel AA
Sci Rep; 2019 Jul; 9(1):9934. PubMed ID: 31289308
[TBL] [Abstract][Full Text] [Related]
7. Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
Strell C; Paulsson J; Jin SB; Tobin NP; Mezheyeuski A; Roswall P; Mutgan C; Mitsios N; Johansson H; Wickberg SM; Svedlund J; Nilsson M; Hall P; Mulder J; Radisky DC; Pietras K; Bergh J; Lendahl U; Wärnberg F; Östman A
J Natl Cancer Inst; 2019 Sep; 111(9):983-995. PubMed ID: 30816935
[TBL] [Abstract][Full Text] [Related]
8. Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer?
Choi DX; Eaton AA; Olcese C; Patil S; Morrow M; Van Zee KJ
Ann Surg Oncol; 2013 Apr; 20(4):1302-10. PubMed ID: 23161115
[TBL] [Abstract][Full Text] [Related]
9. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
[TBL] [Abstract][Full Text] [Related]
10. Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion.
Fang Y; Wu J; Wang W; Fei X; Zong Y; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
Oncotarget; 2016 Sep; 7(39):64182-64190. PubMed ID: 27577080
[TBL] [Abstract][Full Text] [Related]
11. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
Sharma M; Beck AH; Webster JA; Espinosa I; Montgomery K; Varma S; van de Rijn M; Jensen KC; West RB
Breast Cancer Res Treat; 2010 Sep; 123(2):397-404. PubMed ID: 19949854
[TBL] [Abstract][Full Text] [Related]
12. Clinic-Pathological Features of Breast Ductal Carcinoma
Zheng J; Zhou T; Li F; Shi J; Zhang L
Cancer Invest; 2020 Feb; 38(2):113-121. PubMed ID: 31939679
[No Abstract] [Full Text] [Related]
13. Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
Yu BH; Li BZ; Zhou XY; Shi DR; Yang WT
Diagn Pathol; 2018 May; 13(1):36. PubMed ID: 29848352
[TBL] [Abstract][Full Text] [Related]
14. Should ductal carcinoma-in-situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI.
Vicini F; Shah C; Ben Wilkinson J; Keisch M; Beitsch P; Lyden M
Ann Surg Oncol; 2013 Apr; 20(4):1275-81. PubMed ID: 23054123
[TBL] [Abstract][Full Text] [Related]
15. Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component.
Yu KD; Wu LM; Liu GY; Wu J; Di GH; Shen ZZ; Shao ZM
Ann Surg Oncol; 2011 May; 18(5):1342-8. PubMed ID: 21042943
[TBL] [Abstract][Full Text] [Related]
16. Disparities in reconstruction rates after mastectomy for ductal carcinoma in situ (DCIS): patterns of care and factors associated with the use of breast reconstruction for DCIS compared with invasive cancer.
Kruper L; Xu X; Henderson K; Bernstein L
Ann Surg Oncol; 2011 Oct; 18(11):3210-9. PubMed ID: 21863363
[TBL] [Abstract][Full Text] [Related]
17. Invasive ductal breast carcinoma with predominant intraductal component: Clinicopathological features and prognosis.
Sabatier R; Sabiani L; Zemmour C; Taix S; Chereau E; Gonçalves A; Jalaguier-Coudray A; Charafe-Jauffret E; Resbeut M; Extra JM; Viens P; Tallet A
Breast; 2016 Jun; 27():8-14. PubMed ID: 27212694
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Delays in the Treatment of DCIS and the Associated Incidence of Invasive Breast Cancer.
Ward WH; DeMora L; Handorf E; Sigurdson ER; Ross EA; Daly JM; Aggon AA; Bleicher RJ
Ann Surg Oncol; 2020 Feb; 27(2):386-396. PubMed ID: 31562602
[TBL] [Abstract][Full Text] [Related]
19. Grade of ductal carcinoma in situ accompanying infiltrating ductal carcinoma as an independent prognostic factor.
Kim JY; Han W; Moon HG; Park IA; Ahn SK; Kim J; Lee JW; Kim T; Kim MK; Noh DY
Clin Breast Cancer; 2013 Oct; 13(5):385-91. PubMed ID: 23870857
[TBL] [Abstract][Full Text] [Related]
20. Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.
Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
BMC Cancer; 2020 Jun; 20(1):513. PubMed ID: 32493410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
